Determinants of sensitivity to PI3K inhibitors in PIK3CA wildtype gastric tumor cells

被引：0

作者：

Chong, Mei Ling ^{[1
]}

Bhattacharya, Bhaskar ^{[1
]}

Voon, Dominic ^{[1
]}

Ko, King Xin ^{[1
]}

Low, Hong Hui ^{[1
]}

Chang, Ti Ling ^{[1
]}

Wu, Mengchu ^{[1
]}

Tan, Patrick Boon Ooi ^{[2
]}

Loh, Marie Chiew Shia ^{[1
]}

Benoukraf, Touati ^{[1
]}

Huynh The Hung ^{[3
]}

Politz, Oliver ^{[4
]}

Liu, Ningshu ^{[4
]}

Soong, Richie Chuan Teck ^{[1
]}

机构：

[1] Natl Univ Singapore, Singapore 117548, Singapore

[2] Duke NUS Grad Med Sch, Singapore, Singapore

[3] Natl Canc Ctr Singapore, Singapore, Singapore

[4] Bayer Healthcare, Berlin, Germany

来源：

CANCER RESEARCH | 2015年 / 75卷

关键词：

D O I：

10.1158/1538-7445.AM2015-2655

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2655

引用

页数：1

共 50 条

[1] Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
Vasan, Neil
Razavi, Pedram
Johnson, Jared L.
Shao, Hong
Shah, Hardik
Antoine, Alesia
Ladewig, Erik
Gorelick, Alexander
Lin, Ting-Yu
Toska, Eneda
Xu, Guotai
Kazmi, Abiha
Chang, Matthew T.
Taylor, Barry S.
Dickler, Maura N.
Jhaveri, Komal
Chandarlapaty, Sarat
Rabadan, Raul
Reznik, Ed
Smith, Melissa L.
Sebra, Robert
Schimmoller, Frauke
Wilson, Timothy R.
Friedman, Lori S.
Cantley, Lewis C.
Scaltriti, Maurizio
Baselga, Jose
CANCER RESEARCH, 2020, 80 (16)
[2] Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
Vasan, Neil
Razavi, Pedram
Johnson, Jared L.
Shao, Hong
Shah, Hardik
Antoine, Alesia
Ladewig, Erik
Gorelick, Alexander
Lin, Ting-Yu
Toska, Eneda
Xu, Guotai
Kazmi, Abiha
Chang, Matthew T.
Taylor, Barry S.
Dickler, Maura N.
Jhaveri, Komal
Chandarlapaty, Sarat
Rabadan, Raul
Reznik, Ed
Smith, Melissa L.
Sebra, Robert
Schimmoller, Frauke
Wilson, Timothy R.
Friedman, Lori S.
Cantley, Lewis C.
Scaltriti, Maurizio
Baselga, Jose
SCIENCE, 2019, 366 (6466) : 714 - +
[3] Double PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer
Vasan, N.
Razavi, P.
Johnson, J. L.
Shao, H.
Reznik, E.
Smith, M. L.
Sebra, R.
Cantley, L. C.
Scaltriti, M.
Baselga, J.
ANNALS OF ONCOLOGY, 2019, 30 : 1 - 1
[4] PIK3CA Mutations PREDICT RESPONSE TO PI3K/AKT/mTOR INHIBITORS
不详
CANCER DISCOVERY, 2012, 2 (03) : 205 - 205
[5] PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
S N Payne
M E Maher
N H Tran
D R Van De Hey
T M Foley
A E Yueh
A A Leystra
C A Pasch
J J Jeffrey
L Clipson
K A Matkowskyj
D A Deming
Oncogenesis, 2015, 4 : e169 - e169
[6] Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer
Ito, Chie
Nishizuka, Satoshi S.
Ishida, Kazuyuki
Uesugi, Noriyuki
Sugai, Tamotsu
Tamura, Gen
Koeda, Keisuke
Sasaki, Akira
JOURNAL OF SURGICAL RESEARCH, 2017, 212 : 195 - 204
[7] PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
Payne, S. N.
Maher, M. E.
Tran, N. H.
Van De Hey, D. R.
Foley, T. M.
Yueh, A. E.
Leystra, A. A.
Pasch, C. A.
Jeffrey, J. J.
Clipson, L.
Matkowskyj, K. A.
Deming, D. A.
ONCOGENESIS, 2015, 4 : e169 - e169
[8] CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors
Vora, Sadhna R.
Juric, Dejan
Kim, Nayoon
Mino-Kenudson, Mari
Huynh, Tiffany
Costa, Carlotta
Lockerman, Elizabeth L.
Pollack, Sarah F.
Liu, Manway
Li, Xiaoyan
Lehar, Joseph
Wiesmann, Marion
Wartmann, Markus
Chen, Yan
Cao, Z. Alexander
Pinzon-Ortiz, Maria
Kim, Sunkyu
Schlegel, Robert
Huang, Alan
Engelman, Jeffrey A.
CANCER CELL, 2014, 26 (01) : 136 - 149
[9] Double PIK3CA mutations in cis enhance oncogene activation and sensitivity to PI3K alpha inhibitors in breast cancer
Vasan, Neil
Razavi, Pedram
Johnson, Jared
Shao, Hong
Shah, Hardik
Antoine, Alesia
Ladewig, Erik
Gorelick, Alexander
Toska, Eneda
Xu, Guotai
Kazmi, Abiha
Chang, Matthew T.
Taylor, Barry S.
Dickler, Maura N.
Jhaveri, Komal
Rabadan, Raul
Reznik, Ed
Smith, Melissa L.
Sebra, Robert
Cantley, Lewis C.
Scaltriti, Maurizio
Baselga, Jose
CANCER RESEARCH, 2019, 79 (13)
[10] PIK3CA C2 domain deletions hyperactivate PI3K, generate oncogene dependence and are exquisitely sensitive to PI3Kα inhibitors
Croessmann, Sarah
Sheehan, Jonathan
Sliwoski, Gregory
Leelatian, Nalin
He, Jie
Nagy, Rebecca
Balko, Justin M.
Mayer, Ingrid A.
Lanman, Richard B.
Miller, Vincent
Cantley, Lewis C.
Irish, Jonathan M.
Meiler, Jens
Arteaga, Carlos L.
CANCER RESEARCH, 2017, 77

← 1 2 3 4 5 →